PPrivate Fund Data
CompaniesFundsPeopleRankingsScreener

Drug Royalties Cayman Fund II LP

Private Equity FundFund ID 805-8023022373Cayman Islands
Gross assets
$3.5M
Min. investment
$100K
Beneficial owners
20
Size rank
Top 88%
Audited
Yes
Structure
Feeder

About this fund

Drug Royalties Cayman Fund II LP is a private equity fund managed by Stone Ridge Asset Management LLC. The fund reports $3.5 million in gross assets, placing it among the top 88% of private funds by size. The stated minimum investment is $100,000. Its financial statements are audited annually. Private funds are not required to publicly disclose returns; Form ADV reports assets, structure, and service providers, shown above.

Fund details

Fund ID805-8023022373
Fund typePrivate Equity Fund
3(c)(1) exclusionNo
3(c)(7) exclusionYes
Master fundNo
Feeder fundYes
Fund of fundsNo
Relies on exemption from registrationYes
Annual auditYes
Prepared per GAAPYes
Sub-advisedNo
% of assets independently valued100%

Other funds from this manager

FundTypeGross assets
Stone Ridge Opportunities Fund LPHedge$2.29B
Stone Ridge Archimedes Master LPHedge$2.04B
Stone Ridge Energy Acquisition Fund II LPHedge$1.05B
See all 16 funds from this manager — unlock the full record.
Join to unlock · $37/mo

Frequently asked questions

How large is Drug Royalties Cayman Fund II LP?

Drug Royalties Cayman Fund II LP reports $3.5 million in gross assets, among the top 88% of private funds by size.

What is the minimum investment for Drug Royalties Cayman Fund II LP?

The stated minimum investment is $100,000.

Who manages Drug Royalties Cayman Fund II LP?

Drug Royalties Cayman Fund II LP is managed by Stone Ridge Asset Management LLC.

Does Drug Royalties Cayman Fund II LP disclose returns?

No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.

Service providers

Prime broker
None reported
Custodian
Administrator

Reported gross assets

$3.5M▼ 60%
Mar '25 — $8.7MApr '25 — $8.7MMay '25 — $8.7MJun '25 — $8.7MJul '25 — $8.7MAug '25 — $8.7MSep '25 — $8.7MOct '25 — $8.7MNov '25 — $8.7MDec '25 — $8.7MJan '26 — $8.7MFeb '26 — $8.7MMar '26 — $3.5MApr '26 — $3.5MMay '26 — $3.5MJun '26 — $3.5M
Mar '25Form ADV, monthlyJun '26

How this fund compares

Gross assetsTop 88%
Larger than 12% of 67,041 private funds
Gross assets vs Private Equity FundsTop 87%
Larger than 13% of 31,066 private equity funds
Minimum investmentTop 71%
Higher than 29% of funds reporting a minimum

Investor base

Adviser & related persons%
Funds of funds%
Non-U.S. persons73%
Share of the fund's beneficial ownership reported on Form ADV. Categories can overlap.